Literature DB >> 33275358

Factors associated with revisits by patients with SARS-CoV-2 infection discharged from a hospital emergency department.

Beatriz López-Barbeito1, Ana García-Martínez1, Blanca Coll-Vinent1, Arrate Placer1, Carme Font1, Carmen Rosa Vargas1, Carolina Sánchez1, Daniela Piñango1, Elisenda Gómez-Angelats1, David Curtelin1, Emilio Salgado1, Francisco Aya1, Gemma Martínez-Nada1, José Ramón Alonso1, Julia García-Gozalbes1, Leticia Fresco1, Miguel Galicia1, Milagrosa Perea1, Miriam Carbó1, Nerea Iniesta1, Ona Escoda1, Rafael Perelló1, Sandra Cuerpo1, Vanesa Flores1, Xavier Alemany1, Óscar Miró1, Mª Del Mar Ortega1.   

Abstract

OBJECTIVES: To analyze emergency department (ED) revisits from patients discharged with possible coronavirus disease 2019 (COVID-19).
MATERIAL AND METHODS: Retrospective observational study of consecutive patients who came to the ED over a period of 2 months and were diagnosed with possible COVID-19. We analyzed clinical and epidemiologic variables, treatments given in the ED, discharge destination, need to revisit, and reasons for revisits. Patients who did or did not revisit were compared, and factors associated with revisits were explored.
RESULTS: The 2378 patients included had a mean age of 57 years; 49% were women. Of the 925 patients (39%) discharged, 170 (20.5%) revisited the ED, mainly for persistence or progression of symptoms. Sixty-six (38.8%) were hospitalized. Odds ratios (ORs) for the following factors showed an association with revisits: history of rheumatologic disease (OR, 2.97; 95% CI, 1.10-7.99; P = .03), digestive symptoms (OR, 1.73; 95% CI, 1.14-2.63; P = .01), respiratory rate over 20 breaths per minute (OR, 1.03; 95% CI, 1.0-1.06; P = .05), and corticosteroid therapy given in the ED (OR, 7.78; 95% CI, 1.77-14.21, P = .01). Factors associated with hospitalization after revisits were age over 48 years (OR, 2.57; 95% CI, 1 42-4.67; P = .002) and fever (OR, 4.73; 95% CI, 1.99-11.27; P = .001).
CONCLUSION: Patients under the age of 48 years without comorbidity and with normal vitals can be discharged from the ED without fear of complications. A history of rheumatologic disease, fever, digestive symptoms, and a respiratory rate over 20 breaths per minute, or a need for corticosteroid therapy were independently associated with revisits. Fever and age over 48 years were associated with a need for hospitalization.

Entities:  

Keywords:  COVID-19; Emergency health services; Infección; Revisita; Revisits; SARS-CoV-2; Urgencias

Mesh:

Year:  2020        PMID: 33275358

Source DB:  PubMed          Journal:  Emergencias        ISSN: 1137-6821            Impact factor:   3.881


  5 in total

1.  [Revisit after discharge from the emergency department in a cohort of patients with COVID-19 pneumonia and analysis based on the healthcare resource used for follow-up. RESALSEVID study].

Authors:  Arantxa Albert; Pere Llorens; Alfons Aguirre; Francisco Javier Martín-Sánchez; Silvia Mínguez; Oscar Moreno; Carles Ferré; Adrián Valls; Begoña Espinosa; Oscar Murillo; Isabel Cirera; Adriana Gil; Samuel Rivera; Ferran Llopis; Pierre Malchair; Juan Gonzalez Del Castillo; Javier Jacob
Journal:  J Healthc Qual Res       Date:  2022-06-08

2.  Currently available data regarding the potential association between COVID-19 and Guillain-Barre syndrome.

Authors:  Juan González Del Castillo; Jesús Porta-Etessam; Òscar Miró
Journal:  Brain       Date:  2021-04-03       Impact factor: 13.501

Review 3.  Hospital readmissions and emergency department re-presentation of COVID-19 patients: a systematic review.

Authors:  Sasha Peiris; Joseph L Nates; Joao Toledo; Yeh-Li Ho; Ojino Sosa; Victoria Stanford; Sylvain Aldighieri; Ludovic Reveiz
Journal:  Rev Panam Salud Publica       Date:  2022-10-10

4.  An integrated emergency department/hospital at home model in mild COVID-19 pneumonia: feasibility and outcomes after discharge from the emergency department.

Authors:  Pere Llorens; Oscar Moreno-Pérez; Begoña Espinosa; Tamara García; Ana Belén Payá; Sonia Sola; Francisca Molina; Francisco Román; Inmaculada Jiménez; Sergio Guzman; Adriana Gil-Rodrigo; Bárbara Peña-Pardo; Esperanza Merino; Joan Gil; David San-Inocencio; Mariano Andrés; José Sánchez-Payá
Journal:  Intern Emerg Med       Date:  2021-02-24       Impact factor: 3.397

5.  Pulmonary embolism severity and in-hospital mortality: An international comparative study between COVID-19 and non-COVID patients.

Authors:  Òscar Miró; Sònia Jiménez; Pere Llorens; Melanie Roussel; Judith Gorlicki; Eric Jorge García-Lamberechts; Pierrick Le Borgne; Javier Jacob; Anthony Chauvin; Olivier Lucidarme; Guillermo Burillo-Putze; Alfons Aguirre; Fabien Brigant; Laura Lozano; Juan González Del Castillo; Yonathan Freund
Journal:  Eur J Intern Med       Date:  2022-01-28       Impact factor: 7.749

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.